abstract |
Compound of formula (I) as active ingredient [wherein R 1 represents C? 1-2 # 191 alkyl substituted by one or more fluoro substituents; R 2 represents hydrogen, hydroxy, methoxy or ethoxy N represents 0, 1 or 2] or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable diluent or carrier; provided that the compound of formula (I) is in the form of a salt Only the formulation may contain iota-carrageenan and a neutral gelling polymer, a controlled release pharmaceutical composition; such a formulation is useful for the treatment of cardiovascular disorders. [Chemical 1] |